References
- 完譯 中藥大辭典, 圖書出版 鼎談, 서울, pp 53-57, 1997.
- 한국전통과학기술의 국제화에 대한 연구: 생약분야, 한국과학기술재단, 1997.
- Pharmacopoeia of the People's Republic of China, Vol. I; Chemical Industry Press: Beijing, p 65, 2000.
- 전국한의과대학 본초학교수 공저, 本草學, 도서출판 영림사, 서울, pp 367-368, 1991.
- 張民廣 主編, 抗腫瘤中藥的臨床應用, 人民衛生出版社, 北京, pp 220-221, 1997.
- 劉春安 主編, 抗癌中草藥大辭典, 湖北科學技術出版社, pp 265-268, 1994.
- Takaya, Y., Takeuji, Y., Akasaka, M., Nakagawasai, O., Tadano, T., Kisara, K., Kim, H.S., Wataya, Y., Niwa, M. and Oshima, Y. Novel Guaiane Endoperoxides, Nardoguaianone A-D, from Roots and their Antinociceptive and Antimalarial Activities. Tetrahedron 56: 7683-7678, 2000.
- Xiao, P.G. Modern Chinese Materia Medica; Chemical Industry Press: Beijing, p 252, 2002.
- Itokawa, H., Masuyama, K., Morita, H. and Takeya, K. Cytotoxic sesquiterpenes from Nardostachys chinensis. Chem. Pharm. Bull. (Tokyo) 41: 1183-1184, 1993. https://doi.org/10.1248/cpb.41.1183
- Li, P., Matsunaga, K., Yamakuni, T. and Ohizumi, Y. Nardosinone, the first enhancer of neurite outgrowth-promoting activity of staurosporine and dibutyryl cyclic AMP in PC12D cells. Brain Res. Dev. Brain Res. 145: 177-183, 2003. https://doi.org/10.1016/S0165-3806(03)00239-6
- 구병수, 김대근, 최정현, 이동웅. 감송향 정유성분의 흡입 및 경구투여시의 중추신경 억제효과. 생명과학회지 16: 156-161, 2006.
- 4. Yoon, S.H., Ju, S.M., Kim, N.S., Park, S.C., Kim, S.H., Song, Y.S. and Jeon, B.H. Extracellular Signal-regulated Kinase (ERK) is Required for Water Extract of Nardostachys chinersis-Induced Differentiation in HL-60 Cells Kor. J. Ori. Physi. Patho. 20: 1415-1320, 2006.
-
Lee, S.J., Choi, Y.H. and Choi, B.T. Inhibitory Effects of Aqueous Extracts from Nardostachys chinensis on
${\alpha}$ -Melanocyte Stimulating Hormone-induced Melanogenesis in B16F10 Cells. Integrative Biosci. 10: 223-236, 2006. - 박 철, 정 민, 서은아, 권강범, 유도곤 감송향물추출물의 HO-1 발현 촉진을 통한 세포보호 작용 및 항염효과. 동의생리병리학회지 24: 624-629, 2010.
- 백 설, 최재혁, 고성훈, 이용재, 차동석, 박은영, 강양규 전훈감송향의 in vitro 항산화 및 항염증 효과. 동의생리병리학회지 23: 853-859, 2009.
- 오광우, 정지해, 정현철, 조한백, 김송백, 최창민 감송향이 수지상세포 성숙에 미치는 영향. 대한한방부인과학회지 23:14-25, 2010.
- Pharmacopoeia of the People's Republic of China, Vol. I; Chemical Industry Press: Beijing p 65, 2000.
- Koeffler, H.P. Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implication. Blood, 62: 709-721, 1983.
- Kim, J.I., Lee, S.H., Park, J.H., Park, H.J. and Lee, K.T. Induction of differentiation on the human histocytic lymphoma cell line U-937 by Costunolide. Kor. J. Pharmacogn. 30: 7-11, 1999.
- Covacci, V., Bruzzese, N., Sgambato, A., Di Francesco, A., Russo, M.A., Wolf, F.I. and Cittadini, A. Magnesium restriction induces granulocytic differentiation and expression of p27Kip1 in human leukemic HL-60 cells. J. Cell Biochem. 70: 313-322, 1998. https://doi.org/10.1002/(SICI)1097-4644(19980901)70:3<313::AID-JCB4>3.0.CO;2-Q
- Sherr, C.J. and Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149-1163, 1995. https://doi.org/10.1101/gad.9.10.1149
- Brugarolas, J., Chandrasekaran,C., Gordon, J.I., Beach, D., Jacks, T. and Hannon, G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557, 1995. https://doi.org/10.1038/377552a0
- Furukawa, Y., Uenoyama, S., Ohta, M., Tsunoda, A., Griffin, J.D. and Saito, M. Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J. Biol. Chem. 267: 17121-17127, 1992.
- Hui, E.K. and Yung, B.Y. Cell cycle phase-dependent effect of retinoic acid on the induction of granulocytic differentiation in HL-60 promyelocytic leukemia cells. Evidence for sphinganine potentiation of retinoic acid-induced differentiation. FEBS Lett. 318: 193-199. 1993. https://doi.org/10.1016/0014-5793(93)80020-U
- Cooper, S. Revisiting the relationship of the mammalian G1 phase to cell differentiation. J. Theor. Biol. 208: 399-402, 2001. https://doi.org/10.1006/jtbi.2000.2228
- Wang, Q.M., Jones, J.B. and Studzinski, G,P. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 56: 264-267, 1996.
- Seo, B.R., Lee, K.W., Ha, J., Park, H.J., Choi, J.W. and Lee, K.T. Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation. Carcinogenesis 25: 1387-1394, 2004. https://doi.org/10.1093/carcin/bgh143
- Huberman, E. and Callaham, M.F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc. Natl. Acad. Sci. USA. 76: 1293-1297, 1979. https://doi.org/10.1073/pnas.76.3.1293
- Rovera, G., Santoli, D. and Damsky, C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA. 76: 2779-2783, 1979. https://doi.org/10.1073/pnas.76.6.2779
- Collins, S.J., Ruscetti, F.W., Gallagher, R.E. and Gallo, R.C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA. 75: 2458-2462, 1978. https://doi.org/10.1073/pnas.75.5.2458
- Breitman, T.R., Selonick, S.E. and Collins, S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77: 2946-2940, 1980. https://doi.org/10.1073/pnas.77.5.2946
- Spira, A.I. and Carducci, M.A. Differentiation therapy. Curr. Opin. Pharmacol. 3: 338-343, 2003. https://doi.org/10.1016/S1471-4892(03)00081-X
- Lo Coco, F., Zelent, A., Kimchi, A., Carducci, M., Gore, S.D. and Waxman, S. Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. Cancer Res. 62: 5618-5621, 2002.
- Wang, Z., Sun, G., Shen, Z., Chen, S. and Chen, Z. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application. Chin. Med. J. (Engl) 112: 963-967, 1999.
- Aksentijevich, I. and Flinm, I.W. Chronic lymphocytic leukemia: advances in biology and therapeutics. Curr. Opin, Oncol. 15:16-22, 2003. https://doi.org/10.1097/00001622-200301000-00003
- Parmar, S. and Tallman, M.S. Acute promyelocytic leukemia: a review. Expert Opin. Pharmacother. 4: 1379-1392, 2003.
- Sciarra, A., Casale, P., Di Chirio, C., Di Nicola, S. and Di Silverio, F. New aspects on prostate cancer: hereditary form, developmental estrogenization and differentiation therapy. Minerva Urol. Nefrol. 50: 185-190, 1998.
- Walczak, J., Wood, H., Wilding., G. Williams, T. Jr., Bishop, C.W. and Carducci M. Prostate cancer prevention strategies using antiproliferative or differentiating agents. Urology 57: 81-85, 2001. https://doi.org/10.1016/S0090-4295(00)00947-X
- Myers, C.E. Differentiating agents and nontoxic therapies. Urol. Clin. North Am. 26: 341-351, 1999, ix. https://doi.org/10.1016/S0094-0143(05)70074-4
- Yang, Q., Sakurai, T. and Kakudo, K. Retinoid, retinoic acid receptor beta and breast cancer. Breast Cancer Res. Treat. 76: 167-173, 2002. https://doi.org/10.1023/A:1020576606004
- Baj, G., Arnulfo, A., Deaglio, S., Mallone, R., Vigone, A., Rosa, M., Giana, M., Villa, L., Malavasi, F. and Surico, N. Retinoids in breast cancer prevention and treatment. Areview of the liferature. Eur. J. Gynaecol. Oncol. 21: 411-415, 2000.
- Patnaik, A., Rowinsky E.K., Villalona, M.A., Hammond, L.A., Britten, C.D., Siu, L.L., Gortz, A., Felton, S.A., Butron, S., Valone, F.H. and Eckhardt, S.G., A phase I study of pivaloyloxymethylbutyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. Clin. Cancer Res. 8: 2142-2148.